Bumper Offer - Urjas oil Just @ Rs. 1
Pulmocet M is an allopathic medicine The correct dosage of Pulmocet M depends on the patient's age, gender, and medical history. This information has been provided in detail in the dosage section.
Pulmocet M is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
| 13 - 18 years (Adolescent) |
|
Based on research, the following side effects have been observed when Pulmocet M is used -
Severe
Moderate
Mild
Is the use of Pulmocet M safe for pregnant women?
Pulmocet M can cause unwanted side effects in pregnant women. If you experience any side effects, stop taking Pulmocet M right away. Take your doctor's advice before taking it again.
Is the use of Pulmocet M safe during breastfeeding?
If you are breastfeeding, you may experience some harmful effects of Pulmocet M. In case you experience any of these, discontinue its use until you consult your doctor.
What is the effect of Pulmocet M on the Kidneys?
Pulmocet M has very mild side effects on the kidneys.
What is the effect of Pulmocet M on the Liver?
The liver can be affected by Pulmocet M. If you experience any unwanted effects of this drug, stop taking it and consult your doctor. You should restart Pulmocet M only after medical advice.
What is the effect of Pulmocet M on the Heart?
Very few cases of side effects of Pulmocet M on the heart have been reported.
Pulmocet M should not be taken with following medicines due to severe side effects it may cause to patients -
Life Threatening
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Pulmocet M unless your doctor advises you to do so -
Is this Pulmocet M habit forming or addictive?
Pulmocet M does not cause addiction.
Is it safe to drive or operate heavy machinery when consuming?
Pulmocet M does not cause dizziness or sleep, so you can drive a vehicle or operate machinery also.
Is it safe?
Pulmocet M is safe but it is important to consult a doctor before taking it.
Is it able to treat mental disorders?
There is no benefit of taking Pulmocet M for mental disorders.
Interaction between Food and Pulmocet M
There isn't any research available on the side effects of taking Pulmocet M with food.
Interaction between Alcohol and Pulmocet M
Consumption of alcohol and Pulmocet M together may have severe effects on your health.
Yes, Pulmocet M can be taken for relieving symptoms of a cold. However, it is best to consult your doctor for the right line of treatment for the cold.
Take Pulmocet M as directed by your doctor. Do not discontinue the drug suddenly or take it longer than prescribed by your doctor.
No, taking Pulmocet M does not cause high blood pressure. However, if you are experiencing fluctuations in blood pressure while taking this drug. Do not delay, inform your doctor immediately.
No, Pulmocet M is not a decongestant. It is an antihistamine, used to relieve symptoms of allergic rhinitis, urticaria, runny nose, itching eyes/nose, and sneezing.
Pulmocet M is the brand name of levocetirizine. It is a prescription drug that belongs to the class of medications called antihistamine (H1 receptor blocker). It is used in the treatment of allergic rhinitis, urticaria, runny nose, itching eyes/nose, sneezing and other types of allergies.
This medicine data has been created by -
B.Pharma, Pharmacy
7 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Xyzal® (levocetirizine dihydrochloride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 164,167
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 873-874
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 228
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Singulair® (montelukast sodium)
Therapeutic Goods Administration (TGA): Department of Health [Internet]. Governmet of Australia; Package leaflet information for the user; Lukair® (montelukast sodium)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Xyzal® (levocetirizine dihydrochloride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 164,167
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 873-874
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 228
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Singulair® (montelukast sodium)
Therapeutic Goods Administration (TGA): Department of Health [Internet]. Governmet of Australia; Package leaflet information for the user; Lukair® (montelukast sodium)
